https://orcid.org/0000-0001-8195-1526
Supplemental material
Human Vaccines & Immunotherapeutics
Volume 15, 2019 - Issue 12
Research Paper
Safety of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine when administered during pregnancy as part of the maternal immunization program in Brazil: a single center, observational, retrospective, cohort study
Related Research Data
Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence
Source:
Elsevier BV
Increasing incidence of pertussis in Brazil: a retrospective study using surveillance data
Source:
Springer Nature
Maternal Tdap vaccination and risk of infant morbidity
Source:
Elsevier BV
Vaccines in Pregnant Women and Research Initiatives
Source:
Ovid Technologies (Wolters Kluwer Health)
Association of TDAP Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations
Source:
Ovid Technologies (Wolters Kluwer Health)
Evaluation of the Association of Maternal Pertussis Vaccination With Obstetric Events and Birth Outcomes
Source:
Ovid Technologies (Wolters Kluwer Health)
Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination.
Source:
Ovid Technologies (Wolters Kluwer Health)
Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013.
Source:
Elsevier BV
Recent Epidemiologic Trends From 2000 to 2013
Source:
Ovid Technologies (Wolters Kluwer Health)
Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge.
Source:
Oxford University Press (OUP)
A Case-Control Study to Estimate the Effectiveness of Maternal Pertussis Vaccination in Protecting Newborn Infants in England and Wales, 2012–2013
Source:
Oxford University Press (OUP)
Linking provided by
